1
Robert C Ladner, Edward H Cohen, Horacio G Nastri, Kristin L Rookey, Rene Hoet, Hendricus Renerus Jacobus Mattheus Hoogenboom: Methods of constructing libraries comprising displayed and/or expressed members of a diverse family of peptides, polypeptides or proteins and the novel libraries. Dyax, Lando & Anastasi, Shelby J Walker, Laurie Butler Lawrence, October 16, 2012: US08288322 (4 worldwide citation)

A library containing a collection of genetic packages that display a member of a diverse family of peptides, polypeptides or proteins and that collectively display at least a portion of the family, the displayed peptides, polypeptides or proteins being encoded by DNA sequences containing sequences e ...


2
Rory AJ Curtis, Wei Gu: 8105, a novel human sugar transporter family member and uses thereof. Laurie Butler Lawrence, Fish & Richardson PC, June 19, 2003: US20030113841-A1

The invention provides isolated nucleic acids molecules, designated 8105 nucleic acid molecules, which encode novel sugar transporter members. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing 8105 nucleic acid molecules, host cells into which th ...


3
Charles R Wescott, Aaron K Sato: Fibrinogen binding moieties. Laurie Butler Lawrence Esq, Fish & Richardson PC, November 6, 2003: US20030207330-A1

Compositions comprising non-naturally occurring fibrinogen binding moieties are described, together with methods of use thereof, e.g., for detecting or isolating fibrinogen molecules in a solution, for blood circulation imaging, and for linking therapeutics or other molecules to fibrinogen. Preferre ...


4
George L King: Methods of modulating angiogenesis. Laurie Butler Lawrence, Fish & Richardson PC, April 25, 2002: US20020048582-A1

Featured are methods of modulating angiogenesis, e.g., by modulating PKC delta. The methods are useful in the treatment of disorders characterized by aberrant and/or increased blood vessel formation and/or increased permeability. The methods are also useful for treatment a disorder characterized by ...


5
David M Nanus, Shen Ruoqian, Neil Bander: Endopeptidase/anti-PSMA antibody fusion proteins for treatment of cancer. Laurie Butler Lawrence, Fish & Richardson PC, January 9, 2003: US20030007974-A1

A fusion protein for treatment of prostate cancer and other cancers which includes an endopeptidase bound to a monoclonal antibody, or an antigen binding portion thereof, specific for prostate specific membrane antigen (PSMA)expressed either on the tumor cell surface or on the surface of epithelial ...